Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Harvard Business School
Baxter
Boehringer Ingelheim
Mallinckrodt
Johnson and Johnson
Moodys

Last Updated: December 11, 2019

DrugPatentWatch Database Preview

Clotrimazole - Generic Drug Details

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

What are the generic drug sources for clotrimazole and what is the scope of freedom to operate?

Clotrimazole is the generic ingredient in twelve branded drugs marketed by Bayer Healthcare Llc, Fougera Pharms, Glenmark Pharms, Taro, Schering Plough, P And L, Schering, Novitium Pharma, Tasman Pharma, Teva, Bayer Hlthcare, Teva Pharms, Bayer Pharms, Paddock Llc, and West-ward Pharms Int, and is included in twenty-nine NDAs. Additional information is available in the individual branded drug profile pages.

There are eleven drug master file entries for clotrimazole. Twenty-six suppliers are listed for this compound.

Drug Prices for clotrimazole

See drug prices for clotrimazole

Drug Sales Revenue Trends for clotrimazole

See drug sales revenues for clotrimazole

Recent Clinical Trials for clotrimazole

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
University of Sao PauloPhase 1/Phase 2
Bangabandhu Sheikh Mujib Medical University, Dhaka, BangladeshPhase 2
Ache Laboratorios Farmaceuticos S.A.Phase 3

See all clotrimazole clinical trials

Pharmacology for clotrimazole
Medical Subject Heading (MeSH) Categories for clotrimazole

US Patents and Regulatory Information for clotrimazole

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Schering Plough LOTRIMIN clotrimazole SOLUTION;TOPICAL 017613-001 Approved Prior to Jan 1, 1982 DISCN Yes No   Start Trial   Start Trial   Start Trial
Taro CLOTRIMAZOLE clotrimazole SOLUTION;TOPICAL 074580-001 Jul 29, 1996 AT RX No Yes   Start Trial   Start Trial   Start Trial
Bayer Pharms MYCELEX-G clotrimazole TABLET;VAGINAL 019069-001 Apr 19, 1985 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for clotrimazole

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Bayer Hlthcare MYCELEX clotrimazole TROCHE/LOZENGE;ORAL 018713-001 Jun 17, 1983   Start Trial   Start Trial
Bayer Pharms MYCELEX-G clotrimazole TABLET;VAGINAL 019069-001 Apr 19, 1985   Start Trial   Start Trial
Schering LOTRIMIN clotrimazole LOTION;TOPICAL 018813-001 Feb 17, 1984   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Moodys
McKinsey
AstraZeneca
Baxter
Boehringer Ingelheim
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.